Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Smith & Nephew Snats (SNN) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 13,285,100
  • Shares Outstanding, K 439,320
  • Annual Sales, $ 4,634 M
  • Annual Income, $ 410 M
  • 36-Month Beta 0.79
  • Price/Sales N/A
  • Price/Book 3.42

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.80 +1.46%
on 12/28/16
30.76 -1.71%
on 01/17/17
+0.33 (+1.09%)
since 12/23/16
3-Month
26.97 +12.11%
on 11/14/16
30.76 -1.71%
on 01/17/17
+0.11 (+0.35%)
since 10/24/16
52-Week
26.97 +12.11%
on 11/14/16
35.38 -14.54%
on 05/25/16
-2.63 (-7.99%)
since 01/22/16

Most Recent Stories

More News
Research and Markets - The Global Advanced Wound Care Market is Expected to Reach $10,940.7 Million in 2022 with Acelity, Inc., Smith and Nephew plc, Molnlycke Healthcare and ConvaTec Dominating

DUBLIN, Jan 12, 2017 /PRNewswire/ --

SNN : 30.23 (-0.26%)
Research and Markets - The Global Advanced Wound Care Market is Expected to Reach $10,940.7 Million in 2022 with Acelity, Inc., Smith and Nephew plc, Molnlycke Healthcare and ConvaTec Dominating

Research and Markets has announced the addition of the "Global Advanced Wound Care Market - Analysis and Forecast (2016-2022) (Focus on Advanced Wound Care Dressings, NPWT Devices, HBOT Devices, Wound...

SNN : 30.23 (-0.26%)
Young & Associates Secures $17.1 Million Verdict In Patent Infringement Case For Medical Device Technology

Young & Associates, a boutique law firm specializing in complex business litigation, secured a $17.1 million jury verdict that found U.K.-based Smith & Nephew, Inc. and its subsidiary, Austin, Texas based...

SNN : 30.23 (-0.26%)
U.S. Uterine Fibroids Market Worth US $273.6 Million by the end of 2024: Rising Prevalence of Fibroid to Ensure Uptake, Says TMR

The U.S. Uterine Fibroids Market shows a strong presence of players. The top three players in the market are Boston Scientific Corporation, Smith & Nephew, and Hologic, Inc., who hold a share of nearly...

SNN : 30.23 (-0.26%)
BSX : 23.64 (-0.17%)
International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2016

Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 16th and 17th, featuring live webcast presentations from international companies with...

DTEGY : 17.4140 (-1.06%)
SNN : 30.23 (-0.26%)
HCM : 13.62 (-0.07%)
SAP : 89.81 (+0.57%)
FPAFY : 3.7680 (+2.39%)
IMPUY : 4.0700 (+8.24%)
IPSEY : 19.3200 (+0.57%)
MURZY : 0.8116 (-3.23%)
DB : 19.85 (+3.17%)
Enabling Improved Patient Outcomes with Smith & Nephew's Pioneering Episode of Care Assurance Program (eCAP)

Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, announces that the U.S. health and wellness organization, Provider PPI LLC, has adopted its Episode of Care Assurance Program...

SNN : 30.23 (-0.26%)
Michael Kors Appoints Robin Freestone to Board of Directors

Michael Kors Holdings Limited (NYSE:KORS) (the "Company"), a global luxury lifestyle brand, today announced that Robin Freestone has been appointed to the Company's Board of Directors, effective...

SNN : 30.23 (-0.26%)
KORS : 43.30 (+1.74%)
PSO : 7.65 (+3.52%)
Global Extremity Reconstruction Market Worth USD 3,041 Million by 2022 - Analysis, Technologies & Forecasts Report 2014-2022 - Vendors: DePut Synthes, Smith & Nephew, Stryker - Research and Markets

Research and Markets has announced the addition of the "Extremity Reconstruction Market By Type, By Biomaterials - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report to...

SNN : 30.23 (-0.26%)
ConforMIS Names Industry Veteran Mark Augusti President and Chief Executive Officer

ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today that...

SNN : 30.23 (-0.26%)
JPM : 84.87 (+1.39%)
CFMS : 8.43 (+0.84%)
MDSY : 0.99 (+2.06%)
Research and Markets - Global Endoscopy Devices Market, 2022: Major Players Include J&J, Olympus, Medtronic, Boston Scientific, Stryker, Smith & Newphew, Karl Storz & B. Brain Melsungen

Research and Markets has announced the addition of the "Endoscopy Devices Global market - Forecast to 2022" [http://www.researchandmarkets.com/research/dd88lz/endoscopy_devices] report to their offering....

SYK : 121.75 (+0.28%)
BSX : 23.64 (-0.17%)
JNJ : 111.99 (-1.69%)
TFX : 163.95 (+0.14%)
HOCPF : 41.7000 (unch)
TXN : 77.12 (+1.84%)
TITXF : 0.3918 (+4.48%)
SNN : 30.23 (-0.26%)
MDSY : 0.99 (+2.06%)
MDT : 74.09 (-0.91%)
ISRG : 665.90 (+1.66%)
OCPNY : 34.7200 (-1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Support & Resistance

2nd Resistance Point 30.45
1st Resistance Point 30.38
Last Price 30.23
1st Support Level 30.19
2nd Support Level 30.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.